Patients with POEMS are usually at an increased risk of venous or arterial thrombosis (likely due to the thrombogenic potential of elevated VEGF and due to an increase in fibrinopeptide A and thrombin-antithrombin complexes), with nearly 20–30% presenting with one of these complications [32,33]. The gene discussed is VEGFA; the disease is Arterial thrombosis.